SecSonar.com

ProPhase Labs, Inc. (PRPH)

ProPhase Labs, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ProPhase Labs, Inc. (PRPH) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $457.1K. Revenue declined 84.8% year-over-year and free cash flow was negative at -$18.4M. This page tracks PRPH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 96 employees · IPO Apr 4, 1994

Valuation

Valuation & price

$0.11 · as of May 25, 2026 · -98.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.13

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.95$3.01$0.07Jul 25Dec 25Jul 26Jul 7, 25$4.42Jul 9, 25$4.24Jul 11, 25$4.23Jul 15, 25$4.16Jul 17, 25$3.73Jul 21, 25$4.03Jul 23, 25$4.35Jul 25, 25$4.66Jul 29, 25$3.50Jul 31, 25$3.60Aug 4, 25$3.10Aug 6, 25$3.17Aug 11, 25$2.82Aug 13, 25$3.27Aug 15, 25$3.49Aug 19, 25$3.13Aug 21, 25$3.35Aug 25, 25$3.36Aug 27, 25$3.29Aug 29, 25$3.38Sep 3, 25$3.59Sep 5, 25$3.55Sep 9, 25$5.15Sep 11, 25$5.15Sep 16, 25$4.34Sep 18, 25$4.18Sep 22, 25$4.50Sep 24, 25$4.35Sep 26, 25$4.43Sep 30, 25$4.58Oct 2, 25$5.47Oct 6, 25$5.95Oct 8, 25$5.15Oct 10, 25$5.26Oct 14, 25$5.26Oct 16, 25$4.86Oct 21, 25$5.11Oct 23, 25$3.50Oct 27, 25$3.76Oct 29, 25$3.77Oct 31, 25$3.64Nov 4, 25$2.92Nov 6, 25$2.79Nov 10, 25$2.79Nov 12, 25$2.68Nov 14, 25$2.80Nov 18, 25$2.58Nov 20, 25$1.92Nov 25, 25$1.80Nov 28, 25$2.09Dec 2, 25$1.41Dec 4, 25$1.40Dec 8, 25$1.38Dec 10, 25$1.45Dec 12, 25$1.15Dec 16, 25$1.15Dec 18, 25$1.05Dec 22, 25$0.97Dec 24, 25$0.61Dec 29, 25$0.45Jan 2, 26$0.36Jan 6, 26$0.25Jan 8, 26$0.20Jan 12, 26$0.19Jan 14, 26$0.18Jan 16, 26$0.16Jan 21, 26$0.14Jan 23, 26$0.26Jan 27, 26$0.22Jan 29, 26$0.17Feb 2, 26$0.17Feb 4, 26$0.14Feb 9, 26$0.18Feb 11, 26$0.17Feb 13, 26$0.16Feb 18, 26$0.18Feb 20, 26$0.16Feb 24, 26$0.15Feb 26, 26$0.16Mar 2, 26$0.15Mar 4, 26$0.15Mar 6, 26$0.14Mar 10, 26$0.14Mar 12, 26$0.14Mar 17, 26$0.09Mar 19, 26$0.08Mar 23, 26$0.09Mar 25, 26$0.08Mar 27, 26$0.07Mar 31, 26$0.09Apr 2, 26$0.09Apr 7, 26$0.09Apr 9, 26$0.10Apr 13, 26$0.13Apr 15, 26$0.15Apr 17, 26$0.10Apr 22, 26$0.12Apr 24, 26$0.13Apr 28, 26$0.13Apr 30, 26$0.13May 4, 26$0.15May 6, 26$0.14May 8, 26$0.12May 12, 26$0.13May 14, 26$0.12May 18, 26$0.11May 20, 26$0.10May 22, 26$0.11May 28, 26$0.10Jun 1, 26$0.12Jun 3, 26$0.14Jun 5, 26$0.11Jun 9, 26$0.10Jun 11, 26$0.09Jun 15, 26$0.09Jun 17, 26$0.08Jun 22, 26$0.08Jun 24, 26$0.10Jun 26, 26$0.10Jul 2, 26$0.08
$0.0752-week range$6.08
Loading valuation history…

Fundamentals

Key fundamentals

$457.1K

Market cap

-84.8%

Revenue growth (YoY)

-2.2%

Gross margin

-$18.4M

Free cash flow (USD)

$23.9M

Net debt

10.9%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2015 → 2024

FY 2015$20.6MFY 2016$21.0MFY 2017$9.9MFY 2018$13.1MFY 2019$9.9MFY 2020$14.5MFY 2021$79.0MFY 2022$122.6MFY 2023$44.4MFY 2024$6.8M
$20.6M$6.8M

Free cash flow by year

2015 → 2024

FY 2015$-4.2MFY 2016$-1.1MFY 2017$-3.0MFY 2018$-2.3MFY 2019$-1.1MFY 2020$-4.3MFY 2021$-17.9MFY 2022$24.6MFY 2023$-14.5MFY 2024$-18.4M
-$4.2M-$18.4M

Gross margin by year

2020 → 2024

FY 202031.7%FY 202141.5%FY 202257.6%FY 202336.6%FY 2024-2.2%
31.7%-2.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 24, 2026 (EPS $-0.87)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly report10-Q FiledJun 30, 2026Filing
  • Annual report10-K FiledJun 1, 2026Filing

Questions

Frequently asked questions

What is ProPhase Labs, Inc.'s market cap?

ProPhase Labs, Inc. (PRPH) has a market capitalization of $457.1K.

What is PRPH's P/E ratio?

A meaningful P/E ratio is not available for PRPH — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PRPH's price-to-book (P/B) ratio?

PRPH trades at 0.13 times book value per share.

When did ProPhase Labs, Inc. last report earnings?

PRPH last reported earnings on June 24, 2026; the next date is not yet scheduled.

Are insiders buying PRPH stock?

SEC Form 4 filings show no open-market insider buys at ProPhase Labs, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

PRFX

PRF Technologies Ltd.

$368K

AKAN

Akanda Corp.

$706.9K

PTPI

Petros Pharmaceuticals, Inc.

$190.1K

IMCC

IM Cannabis Corp.

$1M

SXTC

China SXT Pharmaceuticals, Inc.

$1.3M

SBFM

Sunshine Biopharma, Inc.

$1.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.